Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

FK506 may stimulate hair growth when applied to the skin.

Patients with thyroid disorders show different symptoms and antibody levels.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Noncultured epidermal cell transplantation is effective for repigmenting stable vitiligo.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

DHT may reduce inflammation caused by certain bacteria in skin cells.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Clonally expanded CD8+ T cells cause alopecia areata.

Improving nerve and immune interactions may help heal chronic wounds.